(CPR) Davide Campari-Milano - Overview

Sector: Consumer Defensive | Industry: Beverages - Wineries & Distilleries | Exchange: MI (Italy) | Market Cap: 6.716m EUR | Total Return: -0.5% in 12m

Aperitifs, Spirits, Wine, Non-Alcoholic Beverages
Total Rating 47
Safety 87
Buy Signal -0.23
Beverages - Wineries & Distilleries
Industry Rotation: +8.7
Market Cap: 7.80B
Avg Turnover: 38.0M
Risk 3d forecast
Volatility36.4%
VaR 5th Pctl5.83%
VaR vs Median-3.17%
Reward TTM
Sharpe Ratio0.02
Rel. Str. IBD17.3
Rel. Str. Peer Group26
Character TTM
Beta-0.142
Beta Downside-0.088
Hurst Exponent0.385
Drawdowns 3y
Max DD59.96%
CAGR/Max DD-0.39
CAGR/Mean DD-0.60
EPS (Earnings per Share) EPS (Earnings per Share) of CPR over the last years for every Quarter: "2021-06": null, "2021-09": null, "2021-12": null, "2022-03": null, "2022-06": 0.08, "2022-09": null, "2022-12": null, "2023-03": null, "2023-06": null, "2023-09": null, "2023-12": null, "2024-03": null, "2024-06": null, "2024-09": null, "2024-12": 0.08, "2025-03": null, "2025-06": null, "2025-12": null,
Qual. Beats: 0
Revenue Revenue of CPR over the last years for every Quarter: 2021-06: 1086.35, 2021-09: 574.8, 2021-12: 1086.35, 2022-03: 534.8, 2022-06: 1348.8, 2022-09: 748.8, 2022-12: 1348.8, 2023-03: 667.9, 2023-06: 1457.8, 2023-09: 743.5, 2023-12: 1460.8, 2024-03: 663.5, 2024-06: 1523.4, 2024-09: 753.6, 2024-12: 1546.4, 2025-03: 665.6, 2025-06: 1527.9, 2025-12: 770.4,
Rev. CAGR: 4.24%
Rev. Trend: 95.0%
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: CPR Davide Campari-Milano

Davide Campari-Milano N.V. is a global producer and distributor of spirits, wines, and non-alcoholic beverages. Founded in 1860 and headquartered in Italy, the company maintains a portfolio of over 50 premium brands, including Aperol, Campari, and Wild Turkey. Its operations span the Americas, EMEA, and Asia-Pacific regions through a mix of owned distribution networks and third-party partnerships.

The company operates within the Distillers & Vintners sub-industry, a sector characterized by high brand equity and long-term inventory maturation cycles. Campari’s business model focuses on Global Priorities, which are high-margin brands that drive the majority of its international growth and scalability.

Further analysis of the companys valuation metrics and competitive positioning is available on ValueRay.

Headlines to Watch Out For
  • Aperol and Campari sales volume drives organic revenue growth in key Western markets
  • Strategic acquisition of Courvoisier cognac shifts product mix and debt leverage profile
  • Rising glass and raw material costs pressure gross margins across premium portfolios
  • Global consumer shift toward bitter aperitifs supports long-term brand equity and pricing power
  • Interest rate fluctuations impact financing costs for aggressive mergers and acquisitions strategy
Piotroski VR-10 (Strict) 5.5
Net Income: 242.2m TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.64 > 1.0
NWC/Revenue: 36.06% < 20% (prev 27.12%; Δ 8.94% < -1%)
CFO/TA 0.08 > 3% & CFO 687.6m > Net Income 242.2m
Net Debt (2.09b) to EBITDA (802.0m): 2.61 < 3
Current Ratio: 2.22 > 1.5 & < 3
Outstanding Shares: last quarter (1.20b) vs 12m ago 5.66% < -2%
Gross Margin: 58.50% > 18% (prev 57.39%; Δ 1.10% > 0.5%)
Asset Turnover: 61.00% > 50% (prev 65.93%; Δ -4.93% > 0%)
Interest Coverage Ratio: 3.24 > 6 (EBIT TTM 653.7m / Interest Expense TTM 201.7m)
Altman Z'' 4.51
A: 0.20 (Total Current Assets 2.96b - Total Current Liabilities 1.34b) / Total Assets 8.11b
B: 0.50 (Retained Earnings 4.08b / Total Assets 8.11b)
C: 0.09 (EBIT TTM 653.7m / Avg Total Assets 7.39b)
D: 0.91 (Book Value of Equity 3.86b / Total Liabilities 4.25b)
Altman-Z'' = 4.51 = AA
Beneish M -3.22
DSRI: 0.82 (Receivables 327.1m/388.8m, Revenue 4.51b/4.40b)
GMI: 0.98 (GM 57.39% / 58.50%)
AQI: 0.93 (AQ_t 0.45 / AQ_t-1 0.48)
SGI: 1.02 (Revenue 4.51b / 4.40b)
TATA: -0.05 (NI 242.2m - CFO 687.6m) / TA 8.11b)
Beneish M = -3.22 (Cap -4..+1) = AA
What is the price of CPR shares?

As of June 06, 2026, the stock is trading at EUR 5.52 with a total of 6,308,094 shares traded.
Over the past week, the price has changed by -1.39%, over one month by -13.01%, over three months by -14.22% and over the past year by -0.46%.

Is CPR a buy, sell or hold?

Davide Campari-Milano has no consensus analysts rating.

Davide Campari-Milano (CPR) - Fundamental Data Overview as of 31 May 2026
Market Cap USD = 7.80b (6.72b EUR * 1.1608 EUR.USD)
P/E Trailing = 19.3172
P/E Forward = 16.9492
P/S = 2.2363
P/B = 1.7367
P/EG = 1.6723
Revenue TTM = 4.51b EUR
EBIT TTM = 653.7m EUR
EBITDA TTM = 802.0m EUR
Long Term Debt = 2.22b EUR (from longTermDebt, last quarter)
Short Term Debt = 272.2m EUR (from shortLongTermDebt, last quarter)
Debt = 2.80b EUR (from shortLongTermDebtTotal, two quarters ago) + Leases 71.6m
Net Debt = 2.09b EUR (calculated: Debt 2.80b - CCE 703.3m)
Enterprise Value = 8.81b EUR (6.72b + Debt 2.80b - CCE 703.3m)
Interest Coverage Ratio = 3.24 (Ebit TTM 653.7m / Interest Expense TTM 201.7m)
EV/FCF = 22.69x (Enterprise Value 8.81b / FCF TTM 388.3m)
FCF Yield = 4.41% (FCF TTM 388.3m / Enterprise Value 8.81b)
FCF Margin = 8.61% (FCF TTM 388.3m / Revenue TTM 4.51b)
Net Margin = 5.37% (Net Income TTM 242.2m / Revenue TTM 4.51b)
Gross Margin = 58.50% ((Revenue TTM 4.51b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Gross Margin QoQ = 57.62% (prev 61.12%)
Tobins Q-Ratio = 1.09 (Enterprise Value 8.81b / Total Assets 8.11b)
Interest Expense / Debt = 7.21% (Interest Expense 201.7m / Debt 2.80b)
Taxrate = 27.66% (127.3m / 460.3m)
NOPAT = 472.9m (EBIT 653.7m * (1 - 27.66%))
Current Ratio = 2.22 (Total Current Assets 2.96b / Total Current Liabilities 1.34b)
Debt / Equity = 0.72 (Debt 2.80b / totalStockholderEquity, last quarter 3.86b)
Debt / EBITDA = 2.61 (Net Debt 2.09b / EBITDA 802.0m)
Debt / FCF = 5.39 (Net Debt 2.09b / FCF TTM 388.3m)
Total Stockholder Equity = 3.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.28% (Net Income 242.2m / Total Assets 8.11b)
RoE = 6.36% (Net Income TTM 242.2m / Total Stockholder Equity 3.81b)
RoCE = 10.85% (EBIT 653.7m / Capital Employed (Equity 3.81b + L.T.Debt 2.22b))
RoIC = 7.22% (NOPAT 472.9m / Invested Capital 6.55b)
WACC = 5.40% (E(6.72b)/V(9.51b) * Re(5.48%) + D(2.80b)/V(9.51b) * Rd(7.21%) * (1-Tc(0.28)))
Discount Rate = 5.48% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 67.42 | Cagr: 5.03%
[DCF] Terminal Value 77.97% ; FCFF base≈317.1m ; Y1≈363.5m ; Y5≈535.0m
[DCF] Fair Price = 4.97 (EV 8.05b - Net Debt 2.09b = Equity 5.96b / Shares 1.20b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 95.01 | Revenue CAGR: 4.24% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=0.31 | Chg30d=-0.06% | Revisions=-50% | GrowthEPS=-2.5% | GrowthRev=+0.1%
EPS next Year (2027-12-31): EPS=0.35 | Chg30d=+0.00% | Revisions=-56% | GrowthEPS=+12.1% | GrowthRev=+4.4%
[Analyst] Revisions Ratio: -56%